This is with reference to the in-principle approval granted by the BSE for the proposed right issue of sattva sukun lifecare limited (""the company''''), wherein the company seeks to raise ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.3 pts more than Nifty Microcap 250 and 3.0 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sattva Sukun Lifecare has received in-principle approval from BSE (dated 27th March 2025) for a proposed Rights Issue to raise ₹49.50 Crore. The company manufactures premium aroma and home decor products including diffusers, essential oils, and decorative lamps. Net proceeds will be used for working capital needs, business expansion, and investments in existing subsidiaries, with flexibility to form or acquire new subsidiaries or invest in high-growth companies. The company reported strong financials with nine-month FY24-25 revenue up 65% to ₹421.14 lakh and net profit up 126% to ₹164.80 lakh, while Q3 FY24-25 revenue rose 29% and net profit grew 84%. The board has also approved ₹3,500 lakhs for subsidiary investments and ₹500 lakhs for business expansion.
Existing shareholders will get the opportunity to subscribe to the Rights Issue and maintain their stake, but there will likely be dilution for those who do not participate. The capital infusion could support growth and expansion, though the issue size of ₹49.50 Crore is significant relative to the company's current scale.